obesity-related-disease

New York Post

Study Links GLP-1 Drugs to Lower Cancer Progression in Four Types

A Cleveland Clinic analysis of 12,112 patients found lower rates of progression to stage 4 disease among those taking GLP-1 medications compared with DPP-4 inhibitors. The observational results will be presented at the 2026 ASCO Annual Meeting.

1 source